Drawing for EMBEDDED SOLUTIONS

USPTO serial 86887877

EMBEDDED SOLUTIONS

Reviewed by CopyMark Law Group

Reg. 5740079Status 710
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
ORNDORFF, LINDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EMBEDDED SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robin C. Vance

ROBIN C. VANCE MCGUIREWOODS LLP800 EAST CANAL STREETGATEWAY PLAZARICHMOND, VA 23219-3916

Goods and services

ClassDescriptionStatusFirst use
035Resourcing services for data management, namely, data processing in the nature of the collection, organization, management, analysis and reporting of data gathered in connection with the conduct of a clinical research trial; resourcing services for biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the biomedical and pharmaceutical industries for business or commercial purposes; providing resources for technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing the services of project management, namely, business project management in the field of clinical trials; providing resources for the services of site management, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, and business management services in the nature of monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; providing resources for the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trialsSECTION 8 - CANCELLEDMar 16, 2016
042Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, medical research, research in the field of biotechnology pharmaceutical research services, medical monitoring, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statistical analysis, medical writing, and drug logistics, all in the field of clinical research; maintenance of databases for others; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for research purposesSECTION 8 - CANCELLEDMar 16, 2016
045Regulatory affairs consulting services, namely, regulatory compliance consulting in the field of pharmaceutical developmentSECTION 8 - CANCELLEDMar 16, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 21, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 23, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 14, 2025C8..CANCELLED SEC. 8 (6-YR)—
Apr 30, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 14, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 28, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 27, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 26, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 23, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 23, 2019EX5GSOU EXTENSION 5 GRANTED—
Mar 23, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 6, 2019IUAFUSE AMENDMENT FILED—
Mar 6, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 4, 2019EXT5SOU EXTENSION 5 FILED—
Mar 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 24, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 22, 2018EX4GSOU EXTENSION 4 GRANTED—
Aug 22, 2018EXT4SOU EXTENSION 4 FILED—
Aug 22, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 26, 2018EX3GSOU EXTENSION 3 GRANTED—
Feb 26, 2018EXT3SOU EXTENSION 3 FILED—
Feb 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 31, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 29, 2017EX2GSOU EXTENSION 2 GRANTED—
Aug 29, 2017EXT2SOU EXTENSION 2 FILED—
Aug 29, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 6, 2017EX1GSOU EXTENSION 1 GRANTED—
Mar 6, 2017EXT1SOU EXTENSION 1 FILED—
Mar 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 6, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 12, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 7, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 26, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2016DOCKASSIGNED TO EXAMINER—
Feb 1, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance